About this episode
The initial public offering ((IPO) of Mankind Pharma Ltd opened for subscription on 25th April and closed just yesterday. The pharma major is reportedly eyeing a valuation of over $6.7 billion.
But in recent years, the Indian stock market has not been very kind to pharmas that have been listed. Since 2010, 17 of them have had IPOs, but four have delisted. Of the remaining, half are trading below their listing price.
Amidst this and the current economic state that is making many postpone their IPOs, Mankind still went ahead with its plan. Why?
Tune in to find out.
Get every episode summarized
Each time Daybreak publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Daybreak
This week in AI: activist robots, doom-laden researchers — so who's the good guy...
Daybreak
India has more tourists than ever. So why is tourism in trouble?
Daybreak
The Government sold Air India to escape its problems. The fix is to buy back in
Daybreak
Nykaa cracked fashion at last. Myntra sees no reason to panic
Daybreak